VANGUARD GROUP INC - MERRIMACK PHARMACEUTICALS IN ownership

MERRIMACK PHARMACEUTICALS IN's ticker is MACKXXXX and the CUSIP is 590328100. A total of 4 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of MERRIMACK PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2017$8,440,000
-73.3%
6,805,886
-33.7%
0.00%
-100.0%
Q1 2017$31,618,000
-15.7%
10,265,752
+11.6%
0.00%0.0%
Q4 2016$37,515,000
-34.4%
9,194,936
+2.1%
0.00%
-33.3%
Q3 2016$57,199,000
+4.1%
9,007,633
-11.7%
0.00%0.0%
Q2 2016$54,958,000
-28.9%
10,196,415
+10.4%
0.00%
-40.0%
Q1 2016$77,324,000
-5.1%
9,238,227
-10.4%
0.01%0.0%
Q4 2015$81,474,000
-2.0%
10,313,245
+5.6%
0.01%
+66.7%
Q3 2015$83,114,000
-28.3%
9,766,632
+4.1%
0.00%
-62.5%
Q2 2015$115,975,000
+12.1%
9,379,287
+7.7%
0.01%
+14.3%
Q1 2015$103,440,000
+38.4%
8,707,054
+31.6%
0.01%
+40.0%
Q4 2014$74,765,000
+51.5%
6,616,429
+17.7%
0.01%
+25.0%
Q3 2014$49,345,000
+25.4%
5,620,186
+4.1%
0.00%
+33.3%
Q2 2014$39,340,000
+48.1%
5,396,583
+2.4%
0.00%
+50.0%
Q1 2014$26,564,000
-0.1%
5,270,626
+5.8%
0.00%0.0%
Q4 2013$26,592,000
+49.0%
4,979,705
+6.0%
0.00%0.0%
Q3 2013$17,847,000
-29.5%
4,696,473
+24.9%
0.00%
-33.3%
Q2 2013$25,302,0003,759,5370.00%
Other shareholders
MERRIMACK PHARMACEUTICALS IN shareholders Q3 2017
NameSharesValueWeighting ↓
DAFNA Capital Management LLC 514,853$2,595,0002.23%
GARRISON BRADFORD & ASSOCIATES INC 98,001$494,0000.48%
Catalyst Capital Advisors LLC 380,896$1,920,0000.44%
Knoll Capital Management, LLC 160,585$809,0000.42%
Tekla Capital Management LLC 757,050$3,816,0000.38%
FULLER & THALER ASSET MANAGEMENT, INC. 524,800$2,645,0000.13%
Integre Asset Management, LLC 103,493$522,0000.12%
CAMBRIDGE TRUST CO 220,003$1,109,0000.10%
JAMISON EATON & WOOD INC /NJ 62,782$316,0000.09%
STONERIDGE INVESTMENT PARTNERS LLC 88,304$445,0000.09%
View complete list of MERRIMACK PHARMACEUTICALS IN shareholders